30 Apr 2024 by admin in UncategorizedComments Eluminex Biosciences Announces FDA Acceptance of Investigational New Drug (IND) Application for EB-105 – A Novel Trispecific Fusion Antibody for Diabetic Macular Edema (DME) – and Upcoming Scientific Presentations
26 Apr 2024 by admin in UncategorizedComments Crescendo Biologics announces that Zai Lab has initiated a global Phase 2 clinical trial evaluating ZL-1102 (Humabody®, CB001) as a topical treatment for psoriasis
08 Apr 2024 by admin in UncategorizedComments Adcentrx Therapeutics Appoints Meng Jiang as Chief Financial Officer
